Signal Genetics is classified as operating in the Medical Laboratories industry, NAICS Code 621511.
Trademark Applications
Trademark applications show the products and services that Signal Genetics is developing and marketing.
Signal Genetics doesn't have any recent trademark applications, indicating Signal Genetics is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
SIGNAL GENETICS Medical testing for prognostic or treatment purposes in the field of cancer; medical testing services for prognosis and stratification of patients at high or low risk of multiple myeloma recurrence; providing an internet website portal for accessing the results of medical diagnostic tests
04/02/2012
MYPRS PLUS Medical testing services for prognosis and stratification of patients at high or low risk of multiple myeloma recurrence
03/20/2012
MYPRS Medical testing services for prognosis and stratification of patients at high or low risk of multiple myeloma recurrence
03/20/2012
See all trademarks and details in the Full Report.
Market Share of Signal Genetics's Largest Competitors
A competitive analysis shows these companies are in the same general field as Signal Genetics, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to Signal Genetics.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
Future Competition: Signal Genetics's Fastest Growing Competitors
These companies are in the same general field as Signal Genetics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.